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The cytoplasmic granules of eosinophils are composed of a crystalloid core sur-
rounded by a matrix and contain the proteins responsible for the effect ofthese cells
in helminth infection and hypersensitivity reactions (1) . Eosinophil peroxidase
(EPO)', an abundant protein in the matrix of the eosinophil granule (1), when com-
bined with H202 and halide, is a potent toxin for parasites (2) and mammalian cells
(3), as well as a mediator of several hypersensitivity mechanisms (4-6) . EPO also
kills helminths and cells in the absence ofH202, indicating that the molecule itself
is a toxin (6, 7) . EPO is a heme-containing protein (8), composed of 14,000- and
58,000-dalton subunits (9) that presumably are translated from the same mRNA
into a larger precursor that is subsequently cleaved (10) . Although its biologic activi-
ties are well established, the structure, amino acid composition, and nucleotide se-
quence of EPO are unknown .
Here, we report the purification and partialamino acid sequence ofEPO subunits .
This information was used to isolate and determine the nucleotide sequence of a
cDNA clone representinghuman EPOmRNA from a cDNA library of eosinophils
from induced human umbilical cord mononuclear cells (MNC) . The comparison
of the nucleotide and the predicted amino acid sequences ofEPO to those of other
reported peroxidases suggests the existence of a peroxidase multigene family.
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Materials and Methods
EPO Purification andMolecular WeightDetermination ofthe Subunits.
￿
Eosinophils were obtained
by cytopheresis of the peripheral blood of patients with hypereosinophilic syndrome . EPO
was purified from eosinophil granules on Sephadex G-50 and CM-Sepharose columns (Phar-
macia Fine Chemicals, Piscataway, NJ), as previously described (11), and the 415/280 nm
ratio of the peak fraction from the CM-Sepharose column was 0.9 . Peroxidase activity of
the purified EPO was determined by measuring A485 nm of the reaction ofEPO with H202
and D-phenylenediamine (data not shown) . To purify EPO subunits, it was dissolved in 6
M guanidine hydrochloride (WhittakerM . A . Bioproducts, Walkersville, MD) at a final con-
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1 Abbreviations used in this paper EPO, eosinophil peroxidase ; MNC, mononuclear cells; MPO, my-
eloperoxidase ; TPO, thyroid peroxidase.
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centration of 1 %, reduced with 0.01 M dithiothreitol, carboxymethylated with 0.02 M iodo-
acetic acid, and applied to a Sepharose CL 6B column (Pharmacia Fine Chemicals) that
had been equilibrated with 6 M guanidine hydrochloride, as described previously (12). Frac-
tions corresponding to molecular weights of the heavy or the light subunits were desalted
on a G-15 column (Pharmacia Fine Chemicals)by elution with 0.5 M acetic acid. The frac-
tions corresponding to each EPO subunit peak were pooled, concentrated in a YM-10 filter
(Amicon Corp., Danvers, MA), and stored at -20°C.
Partial AminoAcid SequenceAnalysis.
￿
The amino acid sequence of the NH2 terminus of each
chain was determined by subjecting the peptides to Edman degradation using a protein se-
quenator (890D ; Beckman Instruments Inc., Palo Alto, CA), and the resulting derivatives
were identified by reverse-phase HPLC (13).
Construction of EPO Probes.
￿
Mixtures of 17-base oligonucleotides of 64-192 degeneracies
were synthesized from the determined amino acid sequence in a DNA synthesizer (380A;
Applied Biosystems, Inc., Foster City, CA), by using the phosphoramidite method (14). Oli-
gonucleotides were purified on G-50 Sepharose columns and stored at -20°C . When ready
for use, the oligomers were 5' labeled with T4 polynucleotide kinase and Y-[12P]ATP (E. I.
duPont de Nemours & Co. Inc., Boston, MA).
Cell Cultures.
￿
Human umbilical cord blood (up to 100 ml) was collected in heparinized
flasks immediately after delivery. The MNC (10'-2 x 108 cells/donor) were separated by cen-
trifugation on Histopaque 1077 (Sigma Chemical Co., St. Louis, MO) and cultured in RPMI
1640 media (Gibco Laboratories, Grand Island, NY), containing 10% calf serum (HyClone
Laboratories, Logan, UT), 50 /M 2-ME (Sigma Chemical Co.), 2 mM L-glutamine (Gibco
Laboratories), 100 U/ml penicillin, 0.1 mg/ml streptomycin (Sigma Chemical Co.), and 10° 70
T cell supernatant (Electronucleonics, Silver Spring, MD), from cellsstimulated with PHA-
* as described before (15). Cells were cultured at a density of 2 x 106/ml at 37°C, in hu-
midified incubators with 5% C02, for 4 wk and half of the media was replaced weekly. The
protocol for obtaining umbilical cord blood was approved by the Mayo Foundation Institu-
tional Review Board.
EPO Staining.
￿
Cord blood cell cultures were monitored for the expression of cyanide-
resistant peroxidase by a modification of a previously described method (16). Briefly, cytospin
preparations were fixed in formalin-acetone for 30 s and stained for 10 min in phosphate
buffer containing 75 mg 3.3 diaminobenzidine tetrahydrochloride (Sigma Chemical Co.),
0.3 ml 3% H202, and 39.2 mg NaCN. Slides were counterstained in hematoxylin (Sigma
Chemical Co.) and mounted with permount (Fisher Scientific Co., Pittsburgh, PA).
Construction of the cDNA Library from Cord Blood Cells.
￿
Cells (109) were lysed on day 7-8
of culture, and the total cellular RNA was isolated by the guanidine-isothiocyanate/CSC12
method (International Biotechnologies Inc., New Haven, CT and BoehringerManheim Bio-
chemicals, Indianapolis, IN) (17). Poly(A)' RNA was purified by oligo-dT-cellulose (Col-
laborative Research, Lexington, MA) column chromatography (18). The integrityof the mRNA
was tested by in vitro translation in rabbit erythrocyte lysates (19). A custom cDNA library
was constructed in the A-zap vector (Stratagene, La Jolla, CA) as described (20).
Screening of thecDNA Library andDNA SequenceAnalysis.
￿
Independent recombinant clones
(8 x 105) in the cord blood cell library were screened by plaque hybridization using the 12p_
labeled oligonucleotides as probes (21). One clone hybridizing to the EPO probes was iso-
lated from the cord blood cell library (22). This clone was digested with Eco RI and Sau
3A (International Biotechnologies Inc.), subjected to electrophoresis in a 1% agarose gel,
and blotted by standard procedures (23) on a gene screen membrane. The membrane was
hybridized with the three 32P-labeled mixed EPO probes and with a mixed probe made from
the amino acid sequence of the eosinophil cationic protein (24), and autoradiographed.
Restriction fragments of the clone were subcloned into single-stranded M13mp10 (25). Both
strands were sequenced by the dideoxynucleotide chain termination method either from the
subcloned fragments or directly from the double-stranded plasmid excised from the X-zap
vector (22, 26). The complete sequence was compared against other peroxidases in the Gene-
Bank" database. The DNAstar computer program (DNAstar, Madison, WI) was used for
the nucleotide and protein analyses and for the sequence comparison.Results
Purification ofEPO Polypeptide Chains and Their PartialAmino Acid Sequence.
￿
EPO
was purified from the eosinophil granules of patients with hypereosinophilic syn-
drome. After reduction and carboxymethylation, the molecular weight ofthe two
EPO subunits was determined by gel filtration (Fig. 1). The results ofeight experi-
ments gave a molecular mass forthe H and L chains of57,000 ( t 4,200) and 11,000
( ± 1,500) daltons, respectively. The N142-terminal 38 and 50 amino acids ofthe H
and L chains, respectively, were determined (Fig. 2) and three degenerate 17 mer
oligonucleotide probes (one for the H and two for the L chain) were synthesized
from the most unique parts of the molecule, as determined by comparison to se-
quences in the PIR' database.
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FIGURE 1.
￿
Gel filtration of EPO on
Sepharose 4B equilibrated with 6 M
guanidine hydrochloride. Peaks1and
4 are the molecular weight markers,
blue dextran (M, 2 x 106) and DNP-
lysine (M, 248), respectively; peaks 2
and 3 correspond to the EPO H and
L chain, respectively.1760
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FIGURE 3 .
￿
Continued on following page .Construction ofa cDNA Libraryfom Human-induced Cord BloodMNC.
￿
Attempts to
identify EPO cDNA clones in aHL-60 cDNA library were unsuccessful andwe were
also not able to identify any other cell line consistently producing EPO. Therefore,
MNC from the umbilical cord blood of five donors were cultured for 4 wk in the
presence of theT cell supernatant . A sample of each culture was stained for cyanide-
resistant peroxidase (specific for EPO) every 3-10 d to monitor the differentiation
of cord blood cell precursors to eosinophils (15) (Fig . 3) . As shown in Fig. 4, the
cells became positive for EPO after 4-6 d in culture, and the percentage ofpositive
FIGURE 3.
￿
Cyanide-resistant peroxidase staining ofcord bloodMNC . (a)Uninduced (original
magnification, 400); (b) induced with T cell supernatant for 25 d (x 400) ; and (c) same as in
B (x 1,000).
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FIGURE 4 .
￿
Induction ofumbilical cord
blood MNC by T cell supernatant .
Each line represents the results of a
single culture . The x-axis represents the
days in culture, and the y-axis
represents the percent of cells that
stained positive for cyanide-resistant
peroxidase .1762
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cells increased up to 80%, after 4 wk . Cells (109) were pooled from the five cultures
and RNA was isolated .
A cDNA library was constructed from poly(A)+ RNA and 8 x 105 independent
recombinant clones were screened by hybridization procedures with thethree oligo-
nucleotide probes described above. A single clone was found to hybridize with the
three probes in both plaque hybridization and Southern blot analysis (Fig. 5) .
Nucleotide Sequence ofEPO cDNA .
￿
After restriction of the cDNA clone with Eco
RI, a2.5-kB insert was subcloned in M13mp10andtheDNA sequence ofboth strands
was determined . As shown in Fig . 6, thecDNA was composed of 2,558 nucleotides,
2,106 of which were in an open reading frame. By comparison to the known partial
EPO subunit amino acid sequences, the cDNA nucleotide sequence was divided
in a 381-bp prosequence, a 333-bp sequence corresponding to the coding region of
the EPO-L chain, a 1,392-bp sequence that codes for theEPO-H chain, and a 452-
bp untranslated region at the 3'endcontaining theAATAAA polyadenylation signal .
The partial amino acid sequence (Fig. 2) was identical to the amino acid sequence
predicted from the nucleotide sequence of theEPO clone, except for the amino acid
24 of the L chain, which was cysteine instead of serine .
The molecular mass ofthe precursor protein, calculated from the predicted amino
acid sequence, was 79,551 daltons, with an isoelectric point of 10.22 . The L and
H chains correspond to 12,712- and 53,011-dalton proteins, with isoelectric points
of 10.8 and 10.7, respectively .
Comparison of the EPO nucleotide sequence to other peroxidases (Table I) re-
vealed a 69.5% overall similarity index to the neutrophil myeloperoxidase (MPO),
with 76% similarity of the H chains and 73% of the L chains . The similarity to
other peroxidases was 40-60% . Comparison ofEPO amino acid sequence to other
peroxidases revealed that EPO and MPO have 68.3% identity, being 69.4% and
70% identical at the L andH chains, respectively (27) (Table 11) . Thyroid peroxi-
dase (TPO) is the second most similar peroxidase to EPO (28) (Tables I and II) .
To determine whether or not a conserved sequence suggestive of active site exists
in all peroxidases, the predicted amino acid sequences of EPO, MPO, andhuman
TPOwere aligned (Fig. 7) . Thehomology was striking throughout the entire mole-
cules, especially at the L and H chains . Therefore, no conclusions can be drawn
about active sites . Comparison with the amino acid sequence of other peroxidases
gave very poor alignment (not shown) indicating no significant homology (Table 1) .
FIGURE 5 .
￿
Southern blot analysis of a cDNA
clone from the cord blood cDNA library. Lanes
1, 3, 5, and 7 digested with Sau-3A ; lanes 2, 4,
6, and 8 digested with EcoRI . ThecDNA clone
was analyzed by hybridization using oligonucleo-
tides derived by reverse translation oftheamino
acid sequences ofEPOH chain, one probe, lanes
1 and 2 ; EPO L chain, two probes, lanes3and
4 and lanes5and 6, respectively ; andECP, lanes
7 and 8 .TEN ET AL.
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TABLE I
Nucleotide and Amino Acid Sequence Homology of EPO and Other Peroxidases
Similarity index
* Reference to the nucleotide sequences of the corresponding peroxidase.
Z values calculated by the Lipman-Pearson method (34); values >10 are considered sig-
nificant .
4 Insufficient homology for alignment.
TABLE II
Nucleotide and Amino Acid Sequence Homology of EPO
Compared with MPO and hTPO
* References for the nucleotide sequences of MPO and hTPO are 27 and 28,
respectively.
$ UTR = 3' untranslated region .
Discussion
Wehave identified a cDNA clonecorrespondingto themRNAofthe human EPO.
The sequence of the clone confirms the existence of a unique mRNA that codes
for a large precursor that contains both the L and the Hchains (10). Furthermore,
this mRNA also contains a prosequence atthe 5' end that codes for a peptide similar
to the prosequence ofthe neutrophil MPO (27). However, a typical leader sequence
was not included in the clone and we were unable to do complete comparisons of
the EPO and MPO preprosequence. Comparison of the EPO sequence with other
peroxidases shows a striking homology, both at the nucleotide and the amino acid
level, suggesting the existence ofa peroxidase multigenefamily that evolved by gene
duplication. The study ofEPO and othereosinophilgranuleproteins hasbeen ham-
pered by the difficulty in obtainingsufficient numbers ofeosinophils, because these
cells exist in the blood in very low numbers, and patients with eosinophilia are not
Source Peroxidase Nucleotide Amino acid
%
Human Myeloperoxidase (27)* 69.5 68 .3 (109)$
Porcine Thyroid peroxidase (29) 60.4 43 .6 (13)
Human Thyroid peroxidase (28) 59 43 .5 (67)
Human Glutathione peroxidase (30) 51 .3 36.4 (0.6)
Chrysosporium Ligninase (31) 49.7 18 (0.6)
Nicotiana tabacum Lignin-forming peroxidase (32) 40.3 18.5 (0.5)
Caldariomyces Chloroperoxidase (33) 15 16 .4 (0.4)
Nucleotide Amino acid
Area of
the molecule
similarity
MPO
index*
hTPO MPO
similarity index
hTPO
%
Total 69.5 59 68.3 43 .5
L chain 73 65.4 69.4 51 .4
H chain 75.8 58.7 70 45.1
UTRI 44.8 50.71764 PEROXIDASE MULTIGENE FAMILY
CAA TTC CGT GGC CAG GAG CCC TGC CAG GGC ACT GAG CCA CCC TCC CCT GGG GCA GTG GAG
￿
60
e f r g q d p c q g t d p a s p g a v e
ACC TCG GTC CTG CGA GAG TGC ATA GCA GAG GCC AAG TTC CTG GTG GAT GCT GCC TAG AAT 120
t s v 1 r d c i a e a k 1 1 v d a a y n
TGG ACC CAG AAC AGC ATC AAG CAG CGG CTT CGC ACC GGT TCA GCC AGC CCC ATG GAG CTC 180
w t q k s i k q r 1 r s g s a s p m d 1
CTG TCC TAG TTC AAA CAA CCG GTA GCA CCC ACC AGG ACA GTT GTT CGG
Gee
GCA GAT TAT 240
1 s y f k q p v a a t r t v v r a a d y
ATG CAT GTG GCT TTG GGG CTG CTT GAA GAG AAG TTA CAA CCC CAG CGG TCC GGA CCC TTC 300
m h v a 1 g 1 1 e e k 1 q p q r s g p f
ATT GTC ACT GAT GTG CTA ACA GAA CCA CAG CTG CGG CTG CTG TCC CAG GCC ACT GGC TGT 360
n v t d v 1 t e p q 1 r 1 1 s q a s g c
GCT CTC CGG GAG CAG GCC GAG CGC TGC AGC GAG AAC TAG CGC ACC ATC ACT GGA CGG TGC 420
a 1 r d q a e r c s d k y r t i t g r c
AAC AAC AAG AGG AGA CCC TTG CTA GGG GCC TCC AAC GAG GCT CTG GCT CCC TGG CTG CCC 480
n n k r r p 1 1 g a s n q a 1 a r w 1 p
GCC GAG TAT GAG GAT GGG CTG TCG CTC CCC TTC GGC TGG ACC CCC AGC AGG AGG CGC AAT 540
a e y e d g 1 s 1 p f g w t p s r r r n
GGC TTC CTT CTC CCT CTT GTC CGG GCT GTC TCC AAC CAG ATT GIG CGC TTC CCC AAT GAG 600
g f 1 1 p 1 v r a v s n q i v r f p n e
AGA CTG ACC TCC GAG CGT GGC CGA GCC CTC ATG TTC ATG CAG TGG GGC CAG TTC ATT GAG 660
r 1 t s d r g r a 1 m f m q w g q f i d
CAT GAG CTG GAG TTC TCC CCG GAG TCC CCG GCC AGA GTG GCC TTC ACT GCA GCC GTT GAG 720
hd1dfspesparvaftag
TGT GAG AGG ACC TGC GCC CAG CTG CCC CCC TGC TTT CCC ATC AAG ATC CCA CCC AAT GAG 780
c e r t c a q 1 p p c f p i k i p p n d
CCC CGC ATC AAG AAC GAG GGT GAG TGC ATC CCT TTC TTC CGC TCG GCA CCC TCA TGC CCC 840
p r i k n q r d c i p f f r s a p s c p
CAA AAC AAG AAC AGA GTC CGC AAC CAG ATC AAC CCG CTC ACC TCC TTT GTG GAG GCC ACC 900
q n k n r v r n q i n a 1 t s f v d a s
ATG GTG TAT GGC ACT GAG GTC TCC CTC TCG CTG CGG CTC CGC AAC CGG ACC AAC TAG CTG 960
m v y g s e v s 1 s 1 r 1 r n r t n y 1
GGG CTG CTG GCC ATC AAC CAG CCC TTT CAA GAG AAC GGC CGG GCC CTG CTG CCC TTC GAG 1020
g 1 1 a i n q r f q d n g r a 1 1 p f d
AAC CTG CAC GAT GAG CCC TGT CTC CTC ACC AAC CGC TCG GCG CCC ATC CCC TGC TTC CTG 1080
n 1 h d d p c 1 1 t n r s a r i p c f 1
GCA GGT GAG ACC CGA TCA ACG GAA ACC CCC AAA CTG GCA CCC ATG CAC ACC CTC TTT ATG 1140
a g d t r s t e t p k 1 a a m h t 1 f m
CGA GAG CAC AAC CGG CTG GCC ACC GAG CTG AGA CCC CTG AAT CCC CGG TGG AAT GGA GAG 1200
r e h n r 1 a t e 1 r r 1 n p r w n g d
FIGURE 6.
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AAA CTG TAG AAT GAG GCT CGG AAG ATC ATG GGG GCC ATC GTC GAG ATC ATC ACC TAG CGA 1260
k 1 y n e a r k i m g a m v q i i t y r
GAG TTT CTG CCC CTG GTT CTG GGC AAG GCC CGG GCC AGG AGA ACC CTG GGG CAC TAG AGG 1320
d f 1 p 1 v 1 g k a r a r r t 1 g h y r
GGG TAG TGC TCC AAT GTG GAG CCA CGG GTG GCC AAT GTC TTC ACC CTG GCC TTC CGC TTT 1380
g y c s n v d p r v a n v f t 1 a f r f
GGC CAC ACA ATG CTC GAG CCC TTC ATG TTC CGC TTG GAG AGT GAG TAG CGG GCC TGC GCA 1440
g h t m 1 q p f m f r 1 d s q y r a s a
CCC AAC TCG CAT GTC CCA CTT AGC TCT GCC TTC TTT GCC AGC TGG CGG ATC GTG TAT GAA 1500
p n s h v p 1 s s a f f a s w r i v y e
GGG GGC ATC GAG CCC ATC CTC CGG GGC CTC ATG GCC ACC GCT GCC AAG CTG AAC CGT GAG 1560
g g i d p 1 1 r g 1 m a t p a k 1 n r q
GAT GCC ATG TTA GTG GAT GAG CTC CGG GAG CGG CTG TTT CGG CAA GTG AGG AGG ATT GGG 1620
d a m 1 v d e 1 r d r 1 f r q v r r i g
CTG GAG CTG GCA GCT CTC AAC ATG CAA CGA AGC CGG GAG CAC GGC CTT CCA GGG TAG AAT 1680
1 d 1 a a 1 n m q r s r d h g 1 p g y n
GCT TGG AGG CGC TTC TGT GGG CTC TCC GAG CCC CGG AAT TTG GCA GAG CTT AGC CGG GTG 1740
a w r r f c g 1 s q p r n 1 a q 1 s r v
CTG AAA AAC GAG GAG TTG GCA AGG AAG TTC CTG AAT TTG TAT GGA ACA CCT GAG AAC ATT 1800
1 k n q d 1 a r k f 1 n 1 y g t p d n i
GAG ATC TGG ATT GGG GCC ATC GCT GAG CCT CTT TTG CCG GGG GCT CGA GTG GGG CCT CTT 1860
d i w i g a i a e p 1 1
CTG GCT TGT CTG TTC GAG AAC GAG TTC AGA AGA GCC GAG AGG GAG ACA GGT TCT GGT GGC 1920
1 a c 1 f e n q f r r a e t e t g s g g
AGA ACC AGG TGT TTT CAC CAA AGA GAG CGC AAG GCC CTG AGC AGA ATT TCC TTG TCT CGA 1980
r t r c f h q r q r k a 1 s r i s 1 s r
ATT ATA TGT GAG AAT ACC GGT ATC ACC AGG GTT TCA AGG GAG ATC TTC AGA GCC AAC ATC 2040
i i c d n t g i t t v s r d i f r a n i
TAG CCT CGG GGC TTT GTG AAC TGC ACC CGT ATC CCC AGG TTG AAC CTA TCA GCC TGG CGA 2100
y p r g f v n c s r i p r 1 n 1 s a w r
GGG ACA TGAGGCTTCTGCAGGAGTCTATCCCAAGTCTCCAACTTTTCGAGACAAGGGGAAGGGGAGGACCATGAGGC 2177
g t
TGCCTTGTCTCCCTGGAGCAAGTGCAGGCTCGTGACGCTTCTGCTGGCTACAGCTCAGAGCTGGGTTCCCCAGCCAGGA 2256
GTGAAGGCTGGGGGCTCCTATCAGCAATGGACCTTCCGCCTTGGGAGCCTCTTAGGTATTAGGCTATGAATCAGCGCCA 2335
CGTGCAAAGGCTTGGGAGCCAAGCCATGTGGTCTTGCACCCCAGGCAAGAAAAGTCAGCTGGAGGGTTTACAGCACTTT 2414
CTACTGTTTCCCAGCCCTCCCTCCCCTCCCTCACCATGACTAAGAGACCACTCGGTCCTAGCCTCCAGACACCCCACAA 2493
TACTCCTCTGAGCCTGAGGCCAGGCAGCATGCTCTGCTTCTACCAATAAAGCACTGCCGGAATTC 2558
P 9 a r v 9 P
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FIGURE 6.
￿
Nucleotide sequence of the EPOclone from the cord blood cell cDNA library. The
predicted aminoacid sequence is displayedbelowthe correspondingnucleotides in theoneletter
code. The NH2-terminal amino acidsof the L and H subunits are underlined. Numbers indi-
cate thenucleotide position. Thesesequence data have been submitted to the EMBL/GenBank
Data Libraries under the accession number X14346.1766
￿
PEROXIDASE MULTIGENE FAMILY
FIGURE 7 .
￿
Amino acid sequence comparison of EPO, MPO, andhTPO . Amino acids that are
identical to all three are boxed. L and H indicate the beginning of the EPO L and H chains,
respectively . References for the nucleotide sequences ofMPO andhTPO are 27 and 28, respectively.
common . The promyelocytic leukemia cell line, HL-60, expresses several eosinophil
granule proteins (35), but we were unable to find a clone corresponding to EPO
in a cDNA library from uninduced HL-60 cells . The establishment of a method
to induce the differentiation ofeosinophils from umbilical cord bloodMNC allowed
us to obtain a sufficient number of cells to construct a cDNA library that presum-
ably contains the sequences that code for eosinophil products . This library has been
helpful to isolate not only a cDNA clone corresponding to EPO, but also another
clone that corresponds to the eosinophil cationic protein (manuscript in prepara-
tion), and can be further used for the study of other eosinophil products .
The cDNA library was constructed fromhuman umbilical cord leukocytes induced
by a PHA-A-stimulated T cell supernatant . This conditioned media was depleted
of IL-2, to avoid the induction to lymphocyte differentiation, and presumably con-
tains IL-5, shown to induce eosinophil differentiation from bone marrow and um-
bilical cord blood cells (15) . The mRNA for the construction of the library was ob-
tained after the cells began to express granules that stained for cyanide-resistant
peroxidase, assuming that the level of mRNA would be maximum at that point .
The predicted amino acid sequence of EPO was identical at the NH2 terminus of
the subunits to the sequence obtained by amino acid sequence analysis, except for
oneamino acid in the L chain . The codon corresponding to that amino acid differed
in a single base in both sequences (TCC vs . TGC) . This amino acid sequence differ-
ence suggests the possibility ofperoxidase polymorphism among different individuals .TEN ET AL.
￿
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The predicted amino acid sequence of EPO shows a 79,551-dalton precursor pro-
tein containing a preprosequence at the NH2-terminus end that presumably is
cleaved to give rise to a 65,723-dalton molecule that is further cleaved into 12,712-
and 53,011-dalton subunits. These predicted molecular masses agree with the results
obtained by gel chromatography by us and others (9), suggesting that the mature
molecule is not glycosylated even though there are N-linked oligosaccharide acceptor
sites in the H chain.
EPO and MPO have similar nucleotide and amino acid sequences and also show
similar protein subunit organization. These results suggest that they have similar
functions in eosinophils and neutrophils during inflammatory reactions. The study
of the molecular biology of EPO should be helpful in understanding the complete
and partial EPO deficiencies reported in some populations (36, 37).
Summary
Human eosinophil peroxidase (EPO) was purified from eosinophil granules de-
rived from the peripheral blood of patients with eosinophilia. The molecular mass
of the H and L subunits was determined by gel filtration to be 57,000 and 11,000
daltons, respectively. The partial amino acid sequences of both subunits were used
to construct oligonucleotides for the screening of several cDNA libraries, including
one derived from human-induced umbilical cord mononuclear cells. A cDNA clone
was isolated corresponding to EPO. The nucleotide sequence revealed an open reading
frame of 2,106 bp, corresponding to a prosequence, L chain, and H chain, in this
order. Comparison of the EPO nucleotide sequence with other peroxidases, such
as myeloperoxidase, suggests the existence of a multigene family.
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